Home

Latest News

12345678910
Freshworks Stock Rises Premarket After Analyst Predicts 19% Upside Potential: Retail Sentiment Flips To ‘Bearish’stocktwits.com
UBS said demand for Freshworks products continued to be a “tale of two cities.”
Via Stocktwits · February 6, 2025
Uber Stock Gets Slew Of Price Target Cuts From Analysts Post Q4 Earnings: Retail Shrugs It Offstocktwits.com
Citi lowered its price target on Uber to $92 from $98 while keeping a ‘Buy’ rating on the shares. JPMorgan lowered its price target on the stock to $90 from $95 while keeping an ‘Overweight’ rating on the shares.
Via Stocktwits · February 6, 2025
Gold And Silver Price Projections Using A Historical Modelcontent/com
The latest projections for Gold & Silver based on our analogs. Note that gold must outperform the stock market for these various targets to be reached.
Via Talk Markets · February 6, 2025
Why the dividend investor may take a look at NYSE:SON.chartmill.com
Balancing Dividends and Fundamentals: The Case of SONOCO PRODUCTS CO (NYSESON).
Via Chartmill · February 6, 2025
Eli Lilly's Blockbuster Obesity Drugs Miss Sales Estimates Again, But Investors Cheer Q4 Earnings Beatstocktwits.com
Older diabetes medicines outperformed expectations, helping offset the shortfall in Lilly’s newer treatments.
Via Stocktwits · February 6, 2025
What Happens When The Music Stops?talkmarkets.com
Government debt has nearly doubled since 2018, topping $36 trillion. Soon, interest expense will eat up the entire federal budget.
Via Talk Markets · February 6, 2025
Is Mastercard Stock a Buy Now?fool.com
Via The Motley Fool · February 6, 2025
Earnings Summary: Bombardier Q4benzinga.com
Via Benzinga · February 6, 2025
Is NYSE:KT suited for dividend investing?chartmill.com
Analyzing KT CORP-SP ADR (NYSEKT)'s Dividend Potential.
Via Chartmill · February 6, 2025
Qualcomm Stock Drops Pre-Market As Licensing Forecast Overshadows Q1 Earnings Beat: Retail Sentiment Remains Strongqualcom
Qualcomm had previously benefited from its agreement with Huawei, but the current outlook excludes potential Huawei licensing revenue, though discussions are ongoing, according to management.
Via Stocktwits · February 6, 2025
Under Armour (NYSE:UAA) Delivers Impressive Q4, Stock Soars
Athletic apparel company Under Armour (NYSEUAA) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 5.7% year on year to $1.40 billion. Its non-GAAP profit of $0.08 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 6, 2025
Black Radiance Announces Partnership with U.S. Figure Skater Starr Andrews
Empowering Women of Color and Elevating Beauty Rituals in Figure Skating
Via News Direct · February 6, 2025
Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.investors.com
The company won three FDA approvals over the past two years. Now, it's angling for two new approvals in 2025.
Via Investor's Business Daily · February 6, 2025
Hilton Worldwide: Net Income Hits $505Mfool.com
Hilton Worldwide delivered better-than-expected earnings as it navigates a challenging backdrop for the hospitality industry.
Via The Motley Fool · February 6, 2025
Here's What UPS' Monumental News Means for Investorsfool.com
Via The Motley Fool · February 6, 2025
Is NASDAQ:QCOM suited for dividend investing?chartmill.com
Is QUALCOMM INC (NASDAQQCOM) a Good Fit for Dividend Investing?
Via Chartmill · February 6, 2025
Should Investors Change Their Artificial Intelligence (AI) Investment Strategy After the DeepSeek Launch?fool.com
Via The Motley Fool · February 6, 2025
Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations
Biopharmaceutical company Bristol Myers Squibb (NYSEBMY) announced better-than-expected revenue in Q4 CY2024, with sales up 7.5% year on year to $12.34 billion. On the other hand, the company’s full-year revenue guidance of $45.5 billion at the midpoint came in 1.7% below analysts’ estimates. Its non-GAAP profit of $1.67 per share was 13.8% above analysts’ consensus estimates.
Via StockStory · February 6, 2025
Walmart Stock Rallies Nearly 14% In 2025 So Far As BNY Mellon, Jennison Add WMT In Q4: Technical Analysis Hints At A Looming Pullbackbenzinga.com
Walmart is hovering around its 52-week high, up nearly 14% this year, however, over-optimistic momentum indicators hint at a likely pullback.
Via Benzinga · February 6, 2025
Philip Morris (NYSE:PM) Surprises With Q4 Sales, Stock Soars
Tobacco company Philip Morris International (NYSEPM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.3% year on year to $9.71 billion. Its non-GAAP profit of $1.55 per share was 3.4% above analysts’ consensus estimates.
Via StockStory · February 6, 2025
Patterson-UTI Stock Trades In Red Pre-Market After Q4 Revenue Miss: Retail Stays Bearishstocktwits.com
The company’s quarterly revenue fell 26.6% to $1.16 billion compared to last year. Analysts, on average, expected the company to post $1.25 billion in revenue.
Via Stocktwits · February 6, 2025
Salesforce Names Board Member As Software Maker's New CFO And COOinvestors.com
The Dow software giant named Robin Washington, as its new CFO and COO.
Via Investor's Business Daily · February 6, 2025
Two Trades To Watch: FTSE 100, EUR/USD Forecast - Thursday, Feb. 6talkmarkets.com
EUR/USD is falling after two days of gains, dropping below 104 as a broad rebound in the US dollar weighs on the pair.
Via Talk Markets · February 6, 2025
Why the quality investor may take a look at COCA-COLA CONSOLIDATED INC (NASDAQ:COKE).chartmill.com
A fundamental analysis of (NASDAQCOKE): Why the quality investor may take a look at COCA-COLA CONSOLIDATED INC NASDAQ:COKENASDAQCOKE)
Via Chartmill · February 6, 2025
Peloton’s (NASDAQ:PTON) Q4 Sales Beat Estimates, Stock Jumps 12.5%
Exercise equipment company Peloton (NASDAQPTON) announced better-than-expected revenue in Q4 CY2024, but sales fell by 9.4% year on year to $673.9 million. On the other hand, next quarter’s revenue guidance of $615 million was less impressive, coming in 6% below analysts’ estimates. Its GAAP loss of $0.24 per share was 25.9% below analysts’ consensus estimates.
Via StockStory · February 6, 2025
The S&P 500 Just Did Something It Hasn't Done in Over Four Decades, and That Could Signal a Big Move in 2025fool.com
The stock market recovery has been a bit lopsided, but that could change soon.
Via The Motley Fool · February 6, 2025
December Had The Second Largest Monthly Trade Deficit In Historytalkmarkets.com
The real (inflation-adjusted) goods deficit increased $14.9 billion, or 15.4 percent, to $111.9 billion in December, compared to a 17.3 percent increase in the nominal deficit.
Via Talk Markets · February 6, 2025
NASDAQ:TLN is an undervalued gem with solid fundamentals.chartmill.com
TALEN ENERGY CORP is a hidden gem, featuring undervaluation and robust fundamentals. NASDAQ:TLN showcases decent financial health and profitability, coupled with an attractive price.
Via Chartmill · February 6, 2025
At Least 40,000 Fed Workers Accept 'DOGE Buyout' As Deadline Looms Tonighttalkmarkets.com
Thursday marked the final day for federal employees to accept the Trump administration's offer of eight months of pay and benefits in exchange for voluntarily stepping down. 
Via Talk Markets · February 6, 2025
Eli Lilly’s Q4 2024 Revenue Surges By 45% To $13.53 Billiontalkmarkets.com
Eli Lilly and Company reported a robust revenue growth of 45% in Q4 2024, reaching $13.53 billion, driven by increased volume from key products.
Via Talk Markets · February 6, 2025
Advanced Drainage’s (NYSE:WMS) Q4 Sales Beat Estimates
Water management company Advanced Drainage Systems (NYSEWMS) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 4.3% year on year to $690.5 million. The company expects the full year’s revenue to be around $2.94 billion, close to analysts’ estimates. Its non-GAAP profit of $1.09 per share was 9.8% below analysts’ consensus estimates.
Via StockStory · February 6, 2025
Honeywell To Split Into 3 Listed Entities Months After Elliott Management’s $5B Stake Buy: Retail Holds Back For Nowstocktwits.com
The three companies—Honeywell Automation, Honeywell Aerospace, and Advanced Materials— will have distinct strategies and growth drivers.
Via Stocktwits · February 6, 2025
XPO’s (NYSE:XPO) Q4 Earnings Results: Revenue In Line With Expectations
Freight delivery company XPO (NYSEXPO) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $1.92 billion. Its non-GAAP profit of $0.89 per share was 41.6% above analysts’ consensus estimates.
Via StockStory · February 6, 2025
Ford CEO Jim Farley Says Trump's Proposed Tariffs On Mexico, Canada Will Be Manageable In Near Term But Will Have 'Huge Impact' If Protractedbenzinga.com
Ford Motor Co CEO Jim Farley addressed the uncertainty surrounding proposed tariffs on imports from Mexico and Canada on U.S. automakers, saying it would wipe out billions of dollars of industry profits if protracted.
Via Benzinga · February 6, 2025
Tapestry (NYSE:TPR) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.6%
Luxury fashion conglomerate Tapestry (NYSETPR) announced better-than-expected revenue in Q4 CY2024, with sales up 5.3% year on year to $2.20 billion. The company’s full-year revenue guidance of $6.85 billion at the midpoint came in 1.4% above analysts’ estimates. Its GAAP profit of $1.38 per share was 12.7% below analysts’ consensus estimates.
Via StockStory · February 6, 2025
Trump's Support For Dollar-Pegged Crypto Will Fast-Track Digital Euro Approval: ECBbenzinga.com
The European Central Bank (ECB) is hopeful that the recent support for dollar-pegged cryptocurrencies from U.S. President Donald Trump will speed up the legislative approval process for the digital euro.
Via Benzinga · February 6, 2025
The Dollar Comes Back Bid - Thursday, Feb. 6talkmarkets.com
After the tariff scare on Monday, which saw the US dollar surge, it has pulled back in the last couple of days.
Via Talk Markets · February 6, 2025
Hershey’s (NYSE:HSY) Q4 Sales Top Estimates
Chocolate company Hershey (NYSEHSY) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 8.7% year on year to $2.89 billion. Its non-GAAP profit of $2.69 per share was 13.3% above analysts’ consensus estimates.
Via StockStory · February 6, 2025
USD/JPY Outlook: Hawkish BoJ Strenghtens Case For Another Hiketalkmarkets.com
BoJ’s Naoki Tamura said on Thursday that the central bank should raise rates to 1%. The dollar remained fragile after a pause in some of Trump’s tariffs. Traders are looking forward to the US nonfarm payrolls report.
Via Talk Markets · February 6, 2025
Eli Lilly Earnings Top, 2025 Guidance Strong, But Weight-Loss Drug Sales Missinvestors.com
Eli Lilly earnings beat Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.
Via Investor's Business Daily · February 6, 2025
Yum! Brands’s (NYSE:YUM) Q4 Earnings Results: Revenue In Line With Expectations
Fast-food company Yum! Brands (NYSEYUM) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 16% year on year to $2.36 billion. Its non-GAAP profit of $1.61 per share was 0.9% above analysts’ consensus estimates.
Via StockStory · February 6, 2025
Bill Gates Says He Donated $100 Billion Of His Wealth For Charitable Causes, But He 'Didn't Order Less Hamburgers Or Less Movies'benzinga.com
Microsoft co-founder Bill Gates on Monday disclosed that he has donated $100 billion to charitable causes.
Via Benzinga · February 6, 2025
3 Best Artificial Intelligence (AI) Stocks to Buy in Februaryfool.com
Via The Motley Fool · February 6, 2025
US Dollar Bounces Off Support After Softening Stance From President Trumptalkmarkets.com
The US Dollar is starting to recover against most major peers in the G10 space.
Via Talk Markets · February 6, 2025
Eli Lilly (NYSE:LLY) Reports Q4 In Line With Expectations, Full-Year Outlook Slightly Exceeds Expectations
Global pharmaceutical company Eli Lilly (NYSELLY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.7% year on year to $13.53 billion. The company’s full-year revenue guidance of $59.5 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $5.32 per share was 4.7% above analysts’ consensus estimates.
Via StockStory · February 6, 2025
Despite its impressive fundamentals, NASDAQ:NTES remains undervalued.chartmill.com
NETEASE INC-ADR may be an undervalued stock option. NASDAQ:NTES retains a strong financial foundation and an attractive price tag.
Via Chartmill · February 6, 2025
BlackBerry Stock Rides ‘FOMO’ Rally To 16-Month High Following Cylance Divestment: Retail Turns Bullishstocktwits.com
While analysts are optimistic about BlackBerry’s Cylance divestment, they are skeptical about its near-term fundamentals.
Via Stocktwits · February 6, 2025
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Omnicell (NASDAQOMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 2.8% above analysts’ consensus estimates.
Via StockStory · February 6, 2025
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · February 6, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · February 6, 2025